These findings along with studies showing that patients on Dasatinib have a reduced risk of pancreatitis19, add a new dimension to the role of Src family members in the acinar cell, and suggest Src as a plausible regulator in pancreatitis. This evidence concerns the gene SRC and pancreatitis.